Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer

Author(s):
Wissing, M.D.; Diest, P.J. van; Wall, E. van der; Gelderblom, H.
Published
2013
Publication type
Article / Letter to editor
aurora kinaseschemotherapyepothilonekinesin spindle proteinmetastatic castrate-resistant prostate cancermitosispolo-like kinase 1taxane
Date issued
2013-05-31
Language
English
Is part of
Expert Opinion on Investigational Drugs (2013), Vol. 22, no. 5, p. 635-661
hdl
1887/100948
doi
10.1517/13543784.2013.789858